Aqr Capital Management LLC Mustang Bio, Inc. Transaction History

Aqr Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.58 - $1.13 $11,575 - $22,552	19,958 Added 123.02%	36,182 $21,000
Q1 2022 May 16, 2022	BUY	$0.73 - $1.81 $3,230 - $8,011	4,426 Added 37.51%	16,224 $16,000
Q2 2021 Aug 16, 2021	SELL	$2.7 - $3.81 $104,814 - $147,904	-38,820 Reduced 76.69%	11,798 $39,000
Q1 2021 May 17, 2021	BUY	$3.02 - $5.16 $152,866 - $261,188	50,618 New	50,618 $168,000
Q4 2020 Feb 16, 2021	SELL	$2.66 - $4.18 $195,254 - $306,828	-73,404 Closed	0 $0

Q3 2020 Nov 16, 2020	BUY	$3.01 - $3.88 $220,946 - $284,807	73,404 New	73,404 $231,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $46.3M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.